Orangekloud Technology (ORKT) Stock Price, News & Analysis

Company Overview

Orangekloud Technology, Inc. is a holding company, which engages in providing information technology consulting services. Its digital transformation projects include the sales and consulting of Microsoft Dynamics ERP software licenses. It operates through the Packaged Software Solutions, and No-Code Platform and Mobile Application segments. The Packaged Software Solutions segment refers to packaged software and custom software solutions. The No-Code Platform and Mobile Application focuses on providing a rapid development environment through a No-Code platform. The company was founded by Kian Hwa Goh, Lay Hua Lung and Kim Chwee Chew on May 12, 2023 and is headquartered in Singapore.

Key Stats

• Today's Range: $0.68 to $0.80
• 50-Day Range: $0.45 to $0.80
• 52-Week Range: $0.40 to $8.00
• Volume: 646,685 shs
• Average Volume: 271,462 shs
• Market Capitalization: $18.56 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.00
• Consensus Rating: Buy

ORKT Stock Analysis - Frequently Asked Questions

How have ORKT shares performed this year?

Orangekloud Technology's stock was trading at $3.02 at the beginning of 2025. Since then, ORKT shares have decreased by 73.7% and is now trading at $0.7947.

When did Orangekloud Technology IPO?

Orangekloud Technology (ORKT) raised $13 million in an IPO on Thursday, July 25th 2024. The company issued 2,800,000 shares at a price of $4.75 per share. Maxim Group served as the underwriter for the IPO.

How do I buy shares of Orangekloud Technology?

Shares of ORKT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Orangekloud Technology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Orangekloud Technology investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

• Today: 7/25/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Technology Services
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:ORKT
• Previous Symbol: NASDAQ:ORKT
• CIK: 1979407
• Web: N/A
• Phone: 65-6317-2050
• Fax: N/A
• Employees: 58
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Orangekloud Technology: $5.00
• High Price Target: $5.00
• Low Price Target: $5.00
• Potential Upside/Downside: +529.2%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 23,360,000
• Free Float: N/A
• Market Cap: $18.56 million
• Optionable: N/A
• Beta: N/A